CDEK
← All drugs Report issue

Lisaftoclax

Small moleculeexperimental

Clinical trial activity

23 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
16
Phase 2
13
Phase 3
4
Phase 4
0

Earliest trial started Aug 7, 2018 (NCT03537482)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07255963Phase 2Nov 30, 2025Soochow University
NCT07272499Phase 2Sep 10, 2025Anhui Medical University, Central South University, Fudan University, Fujian Medical University, Jiao Tong University, Shandong University, Tongji University, Wenzhou Medical University
NCT06641414Phase 3Oct 31, 2024Ascentage Pharma Group Inc., Peking University, University of Texas at Houston
NCT06401603Phase 1Aug 6, 2024Ascentage Pharma Group Inc., University of Texas at Houston
NCT06389292Phase 3Jun 11, 2024Ascentage Pharma Group Inc., Chinese Academy of Medical Sciences, Zhejiang University
NCT06319456Phase 3Apr 7, 2024Ascentage Pharma Group Inc., Chinese Academy of Medical Sciences
NCT06182969Phase 1/Phase 2 (Phase 2)Dec 31, 2023Ascentage Pharma Group Inc., Government of China, Jiao Tong University
NCT06104566Phase 3Dec 20, 2023Ascentage Pharma Group Inc.
NCT05701306Phase 1Mar 23, 2023Ascentage Pharma Group Inc., Government of China, Sun Yat-Sen University
NCT05517616Phase 1Sep 18, 2022Ascentage Pharma Group Inc., Soochow University
NCT05495035Phase 1Sep 1, 2022China Academy of Chinese Medical Sciences, Chinese Academy of Medical Sciences
NCT05147467Phase 2Jan 31, 2022Ascentage Pharma Group Inc., Nanjing Medical University
NCT04946864Phase 1/Phase 2 (Phase 2)Aug 13, 2021Ascentage Pharma Group Inc.
NCT04964518Phase 1Jul 30, 2021Ascentage Pharma Group Inc.
NCT04942067Phase 1/Phase 2 (Phase 2)Jun 1, 2021Ascentage Pharma Group Inc.
NCT04674514Phase 1/Phase 2 (Phase 2)Apr 13, 2021Ascentage Pharma Group Inc., Government of China
NCT04496349Phase 1Dec 1, 2020Ascentage Pharma Group Inc.
NCT04501120Phase 1/Phase 2 (Phase 2)Sep 28, 2020Ascentage Pharma Group Inc., Government of China, Suzhou Yasheng Pharmaceutical Co., Ltd
NCT04494503Phase 1/Phase 2 (Phase 2)Aug 31, 2020Ascentage Pharma Group Inc.
NCT04260217Phase 1Jan 30, 2020Ascentage Pharma Group Inc.
Showing 20 of 23 trials
Page 1 / 2

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ascentage Pharma Group Inc.For profit201932018
Chinese Academy of Medical SciencesAcademic/Hospital4022019
Government of ChinaGovernment4022020
Jiao Tong UniversityAcademic/Hospital2112023
Soochow UniversityAcademic/Hospital2122022
University of Texas at HoustonAcademic/Hospital2122024
Anhui Medical UniversityAcademic/Hospital1012025
Central South UniversityAcademic/Hospital1012025
China Academy of Chinese Medical SciencesAcademic/Hospital1112022
Fudan UniversityAcademic/Hospital1012025
Fujian Medical UniversityAcademic/Hospital1012025
Nanjing Medical UniversityAcademic/Hospital1012022
Peking UniversityAcademic/Hospital1012024
Shandong UniversityAcademic/Hospital1012025
Sun Yat-Sen UniversityAcademic/Hospital1012023
Suzhou Yasheng Pharmaceutical Co., LtdFor profit1012020
Tongji UniversityAcademic/Hospital1012025
Wenzhou Medical UniversityAcademic/Hospital1012025
Zhejiang UniversityAcademic/Hospital1012024
19 organizations
Page 1 / 1